| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |